Won Hoon Jung

835 total citations
40 papers, 720 citations indexed

About

Won Hoon Jung is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Won Hoon Jung has authored 40 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Won Hoon Jung's work include Adipose Tissue and Metabolism (10 papers), Hormonal Regulation and Hypertension (10 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Won Hoon Jung is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Hormonal Regulation and Hypertension (10 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Won Hoon Jung collaborates with scholars based in South Korea, India and Bangladesh. Won Hoon Jung's co-authors include Jin Hee Ahn, Hyae Gyeong Cheon, Sang Dal Rhee, Ki Young Kim, Sung Bum Park, Sung Soo Kim, Seung Kyu Kang, Hee Youn Kim, Kwang Rok Kim and Sung‐Don Yang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Won Hoon Jung

39 papers receiving 707 citations

Peers

Won Hoon Jung
Sang Dal Rhee South Korea
Mahmoud El‐Daly Egypt
Atul Rawat India
Matthias Schittmayer Austria
Vikram Khedgikar India
Arzu Yılmaztepe Oral Türkiye
Waseem El‐Huneidi United Arab Emirates
Cédric Duret France
Claudia von Montfort Germany
Lukáš Werner Czechia
Sang Dal Rhee South Korea
Won Hoon Jung
Citations per year, relative to Won Hoon Jung Won Hoon Jung (= 1×) peers Sang Dal Rhee

Countries citing papers authored by Won Hoon Jung

Since Specialization
Citations

This map shows the geographic impact of Won Hoon Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Hoon Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Hoon Jung more than expected).

Fields of papers citing papers by Won Hoon Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won Hoon Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Hoon Jung. The network helps show where Won Hoon Jung may publish in the future.

Co-authorship network of co-authors of Won Hoon Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Won Hoon Jung. A scholar is included among the top collaborators of Won Hoon Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won Hoon Jung. Won Hoon Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Sung Bum, Seong Soon Kim, Won Hoon Jung, et al.. (2025). Microplastics Accumulation Induces Kynurenine-Derived Neurotoxicity in Cerebral Organoids and Mouse Brain. Biomolecules & Therapeutics. 33(3). 447–457. 4 indexed citations
2.
Jung, Won Hoon, et al.. (2025). Development of 3D Muscle Cell Culture-Based Screening System for Metabolic Syndrome Drug Research. Tissue Engineering Part C Methods. 31(2). 53–64. 1 indexed citations
3.
Lee, Joon Ho, et al.. (2022). Development of in vitro three-dimensional drug screening system for obesity-related metabolic syndrome. Journal of Pharmacological Sciences. 148(4). 377–386. 6 indexed citations
4.
Park, Sung Bum, Won Hoon Jung, Kyoung Jin Choi, Byumseok Koh, & Ki Young Kim. (2022). A Comparative Systematic Analysis of The Influence of Microplastics on Colon Cells, Mouse and Colon Organoids. Tissue Engineering and Regenerative Medicine. 20(1). 49–58. 22 indexed citations
5.
Lee, Jeong Hyun, Sung Bum Park, Haushabhau S. Pagire, et al.. (2019). Optimization of cyclic sulfamide derivatives as 11β-hydroxysteroid dehydrogenase 1 inhibitors for the potential treatment of ischemic brain injury. Bioorganic & Medicinal Chemistry Letters. 30(2). 126787–126787. 8 indexed citations
6.
Jung, Won Hoon, et al.. (2019). Protective effect of a novel selective 11β-HSD1 inhibitor on eye ischemia-reperfusion induced glaucoma. Biochemical Pharmacology. 169. 113632–113632. 11 indexed citations
7.
Kim, Hyojin, Seung Kyu Kang, Kwang Rok Kim, et al.. (2017). Synthesis and biological evaluation of thiazole derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 27(23). 5213–5220. 20 indexed citations
8.
Park, Sung Bum, Ji Seon Park, Won Hoon Jung, et al.. (2016). Anti-inflammatory effect of a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor via the stimulation of heme oxygenase-1 in LPS-activated mice and J774.1 murine macrophages. Journal of Pharmacological Sciences. 131(4). 241–250. 13 indexed citations
9.
Park, Sung Bum, Hyo‐Jin Jeon, Won Hoon Jung, et al.. (2015). Optimization of Enzyme Activity Assay for Screening of Acryl CoA: Monoacylglycerol Acyltransferase 2 Inhibitors. Bulletin of the Korean Chemical Society. 36(5). 1433–1438. 1 indexed citations
10.
Choi, Sik‐Won, You Hwa Son, Sung Bum Park, et al.. (2014). A novel 11β-HSD1 inhibitor improves diabesity and osteoblast differentiation. Journal of Molecular Endocrinology. 52(2). 191–202. 22 indexed citations
11.
Kang, Seung Kyu, Kwan‐Young Jung, Ashok Kumar Jaladi, et al.. (2014). Synthesis and biological evaluation of thienopyrimidine derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(17). 4281–4285. 10 indexed citations
12.
Park, Sung Bum, Won Hoon Jung, Nam Sook Kang, et al.. (2013). Anti-diabetic and anti-inflammatory effect of a novel selective 11β-HSD1 inhibitor in the diet-induced obese mice. European Journal of Pharmacology. 721(1-3). 70–79. 12 indexed citations
13.
Kwak, Hyun Jung, Ji Young Kim, Haushabhau S. Pagire, et al.. (2013). Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents. Bioorganic & Medicinal Chemistry Letters. 23(16). 4713–4718. 41 indexed citations
14.
Bok, Ju Han, Jae Hong Lee, Seung Kyu Kang, et al.. (2012). Synthesis and Biological Evaluation of Cyclic Sulfamide Derivatives as 11β-Hydroxysteroid Dehydrogenase 1 Inhibitors. ACS Medicinal Chemistry Letters. 3(2). 88–93. 17 indexed citations
15.
16.
Kim, Ki Young, Joo Young Kim, Yoon-Young Sung, et al.. (2011). Inhibitory effect of leptin on rosiglitazone-induced differentiation of primary adipocytes prepared from TallyHO/Jng mice. Biochemical and Biophysical Research Communications. 406(4). 584–589. 5 indexed citations
17.
Bae, Myung‐Ae, Sang Dal Rhee, Won Hoon Jung, et al.. (2010). Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new PPARγ agonist KR62776. Archives of Pharmacal Research. 33(3). 433–442. 22 indexed citations
18.
Rhee, Sang Dal, Yoon-Young Sung, Won Hoon Jung, & Hyae Gyeong Cheon. (2008). Leptin inhibits rosiglitazone-induced adipogenesis in murine primary adipocytes. Molecular and Cellular Endocrinology. 294(1-2). 61–69. 30 indexed citations
19.
20.
Sung, Yoon-Young, Young‐Sil Lee, Won Hoon Jung, et al.. (2005). Glucose intolerance in young TallyHo mice is induced by leptin-mediated inhibition of insulin secretion. Biochemical and Biophysical Research Communications. 338(4). 1779–1787. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang Dal Rhee Breakdown of academic impact, for papers by Mahmoud El‐Daly Breakdown of academic impact, for papers by Atul Rawat Breakdown of academic impact, for papers by Matthias Schittmayer Breakdown of academic impact, for papers by Vikram Khedgikar Breakdown of academic impact, for papers by Arzu Yılmaztepe Oral Breakdown of academic impact, for papers by Waseem El‐Huneidi Breakdown of academic impact, for papers by Cédric Duret Breakdown of academic impact, for papers by Claudia von Montfort Breakdown of academic impact, for papers by Lukáš Werner
Rankless by CCL
2026